publication venue for
- Heart transplant in a factor VIII-deficient patient with a high-titre inhibitor: perioperative management using high-dose continuous infusion factor VIII and recombinant factor VIIa. 2001
- Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remain. 2022
- Natural history study of factor IX deficiency with focus on treatment and complications (B-Natural).. 27. 2020
- Long-term safety and efficacy results from the phase 3b, open-label, multicentre Continuation study of rurioctocog alfa pegol for prophylaxis in previously treated patients with severe haemophilia A.. 26. 2020
- Prevalence of FVIII inhibitors in severe haemophilia A patients: Effect of treatment and genetic factors in an Indian population.. 25. 2018
- Radionuclide synovectomy/synoviorthesis (RS) in patients with bleeding disorders: A review of patient and procedure demographics and functional outcomes in the ATHNdataset.. 23. 2017
- Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study.. 21. 2015
- Severe and moderate haemophilia A and B in US females.. 20. 2014
- Use of global assays to understand clinical phenotype in congenital factor VII deficiency.. 19. 2013
- Prevalence of clinical hip abnormalities in haemophilia A and B: an analysis of the UDC database.. 19. 2012
- Haemostasis prophylaxis using single dose desmopressin acetate and extended use epsilon aminocaproic acid for adenotonsillectomy in patients with type 1 von Willebrand disease.. 18. 2011
- Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004-2008).. 16. 2010
- Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project.. 15. 2009
- Risk factors for inhibitor formation in haemophilia: a prevalent case-control study.. 15. 2009
- Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease.. 15. 2009
- Haemophilia in the first years of life.. 14 Suppl 3. 2008
- Immune tolerance therapy utilizing factor VIII/von Willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors.. 14. 2007
- A retrospective postlicensure survey of FEIBA efficacy and safety.. 12. 2006
- Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A.. 10. 2004
- Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection.. 9. 2003
- Inherited coagulation disorders in southern Iran.. 8. 2002
- Radionuclide synovectomy/synoviorthesis (RS) in persons with bleeding disorders: A review of impact of national guidance on frequency of RS using the ATHNdataset.. 23. 2017
- Management strategies in patients with diffuse large B-cell lymphoma and severe haemophilia.. 21. 2015
- Pulmonary embolism in a patient with congenital afibrinogenemia.. 19. 2013
- Peri- and postoperative haematologic management in a patient with type 2 von Willebrand disease undergoing mitral valve replacement.. 17. 2011
- With blood in the joint - what happens next? Could activation of a pro-inflammatory signalling axis leading to iRhom2/TNFα-convertase-dependent release of TNFα contribute to haemophilic arthropathy? 2014
- A child with acquired factor XIII deficiency: case report and literature review. 2013
- Inhibitor treatment in haemophilias A and B: inhibitor diagnosis. 2006
- Gene therapy ethics and haemophilia: an inevitable therapeutic future? 2003
- A review of the pharmacokinetics, efficacy and safety of high-purity factor X for the prophylactic treatment of hereditary factor X deficiency. 2022